Summary
Cyprotex Plc (Cyprotex) provider of ADME-Tox contract research services. It provides these services to the Biotechnology, pharmaceutical, cosmetics/personal care, and chemical industries. The company’s core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including proprietary CellCiphr toxicity prediction technology, predictive modelling using QSAR and PBPK techniques, including Cloe PK for in vivo PK prediction, and a range of endocrine and skin, ocular disruption services. Cyprotex partners with various organizations within the cosmetics and personal care industry, biotech and pharmaceutical industry, and the chemical industry. The company's operations are primarily carried out in the UK and the US. Cyprotex is headquartered in Cheshire, UK.
Cyprotex Plc (CRX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cyprotex Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cyprotex Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cyprotex Plc, Medical Equipment, Deal Details 10
Partnerships 10
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 10
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 11
Acquisition 11
Evotec Acquires Cyprotex for USD68 Million 11
Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 13
Cyprotex Plc - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 02, 2016: Cyprotex: Interim Results 2016 18
Apr 01, 2016: Cyprotex Announces Final results for the year ended 31 December 2015 21
Corporate Communications 22
Sep 26, 2016: Cyprotex: Cyprotex appoint new Director of US Operations 22
Sep 26, 2016: Cyprotex appoint new Director of US Operations 23
Other Significant Developments 24
Jun 09, 2016: Cyprotex Purchase New IntelliCyt iQue Screener for Expansion of Cell-Based Services 24
Apr 26, 2016: Launch of GLP-Compliant Genotoxicity Services 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
Cyprotex Plc, Medical Equipment, Key Facts, 2015 1
Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cyprotex Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cyprotex Plc, Deals By Market, 2011 to YTD 2017 8
Cyprotex Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 10
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 11
Evotec Acquires Cyprotex for USD68 Million 11
Apredica Acquires CeeTox, In-Vitro Toxicological Assays And Screening Data Provider, For Up To US$6 Million 13
Cyprotex Plc, Key Competitors 15
Cyprotex Plc, Key Employees 16
Cyprotex Plc, Subsidiaries 17
List of Figures
Cyprotex Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Cyprotex Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Cyprotex Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Cyprotex Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Cyprotex Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Cyprotex Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8